Recent studies by our group and others have demonstrated that ventricular myocardium is not homogeneous as previously thought, but is comprised of at least three electrophysiologically and functionally distinct cell types: epicardium, endocardium and a unique population of cells that we termed M cells, displaying characteristics intermediate between those of ventricular myocardial and Purkinje cells. The three cell types differ with respect to early and late repolarization characteristics. These distinctions have been shown to underlie the various waveforms of the ECG and when amplified create the substrate for the development of life-threatening ventricular arrhythmias, including the polymorphic ventricular arrhythmias associated with the long QT and Brugada syndromes. We and others have recently reported that both syndromes may also be responsible for sudden death in children and infants and may contribute at some level to sudden infant death syndrome (SIDS). Our basis for understanding the mechanisms involved are hampered by the near total absence of data regarding the developmental aspects of electrical heterogeneity in ventricular myocardium of larger mammals. An urgent need to close this gap in our knowledge is the motivating force and the principal aim of this competing renewal. Our objectives are to define the developmental stages at which these heterogeneities normally arise in the canine heart and to probe how ion channel defects known to contribute to the long QT and Brugada syndromes may intervene to disrupt the normal electrical function of the heart and set the stage for malignant arrhythmias in the early stages of life. Our principal goals are to probe the extent to which electrical heterogeneity exists within the heart at each stage of development, to identify the underlying mechanisms as well as the conditions and interventions that amplify or diminish the intrinsic differences in regional electrical behavior and to examine to what extent transmural electrical heterogeneity is responsible for developmental changes in the ECG. To achieve these goals, we propose to use a multilevel approach designed to provide and integrate voltage clamp and action potential data from isolated myocytes, tissues and arterially perfused canine ventricular wedge preparations. Our long-range goal is to generate information that will contribute to our understanding of the causes for arrhythmic death in infants and young children.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL047678-09
Application #
6370701
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Spooner, Peter
Project Start
1993-05-01
Project End
2005-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
9
Fiscal Year
2001
Total Cost
$432,500
Indirect Cost
Name
Masonic Medical Research Laboratory, Inc
Department
Type
DUNS #
077307437
City
Utica
State
NY
Country
United States
Zip Code
13501
Burashnikov, Alexander; Antzelevitch, Charles (2018) Is extensive atrial fibrosis in the setting of heart failure associated with a reduced atrial fibrillation burden? Pacing Clin Electrophysiol 41:1289-1297
Hasdemir, Can; Juang, Jimmy Jyh-Ming; Kose, Sedat et al. (2018) Coexistence of atrioventricular accessory pathways and drug-induced type 1 Brugada pattern. Pacing Clin Electrophysiol 41:1078-1092
Savio-Galimberti, Eleonora; Argenziano, Mariana; Antzelevitch, Charles (2018) Cardiac Arrhythmias Related to Sodium Channel Dysfunction. Handb Exp Pharmacol 246:331-354
Di Diego, José M; Antzelevitch, Charles (2018) J wave syndromes as a cause of malignant cardiac arrhythmias. Pacing Clin Electrophysiol :
Krych, Michalina; Biernacka, El?bieta Katarzyna; Poni?ska, Joanna et al. (2017) Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene. J Cardiol 70:504-510
Patocskai, Bence; Yoon, Namsik; Antzelevitch, Charles (2017) Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome. JACC Clin Electrophysiol 3:353-363
Antzelevitch, Charles; Patocskai, Bence (2017) Ajmaline-Induced Slowing of Conduction in the Right Ventricular Outflow Tract Cannot Account for ST Elevation in Patients With Type I Brugada ECG. Circ Arrhythm Electrophysiol 10:
Mizusawa, Yuka; Morita, Hiroshi; Adler, Arnon et al. (2016) Prognostic significance of fever-induced Brugada syndrome. Heart Rhythm 13:1515-20
Patocskai, Bence; Barajas-Martinez, Hector; Hu, Dan et al. (2016) Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome. Heart Rhythm 13:1326-34
Antzelevitch, Charles; Patocskai, Bence (2016) Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects. Curr Probl Cardiol 41:7-57

Showing the most recent 10 out of 225 publications